• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. Siponimod inhibits disease-associated microglia-T cell interactions in chronic experimental autoimmune encephalomyelitis
 
  • Details
  • Full
Options
2025
Journal Article
Title

Siponimod inhibits disease-associated microglia-T cell interactions in chronic experimental autoimmune encephalomyelitis

Abstract
Chronically inflamed, reactive microglia represent a prominent feature of secondary progressive multiple sclerosis (SPMS). Especially their interplay with encephalitogenic T cells promotes neuroaxonal damage associated with disease progression. In our study, we aimed to explore the potential of siponimod, a sphingosine-1-phosphate modulator approved for the treatment of active SPMS, to inhibit disease-associated T cell-microglia interactions using a chronic murine experimental autoimmune encephalomyelitis (EAE) model of MS. We found that therapeutic siponimod treatment of chronic EAE improved clinical severity accompanied by reduced demyelination and neuroaxonal damage, diminished CNS T cell infiltration and altered proinflammatory microglia responses. This effect was partly attributed to a direct effect on microglia, as siponimod pretreatment inhibited interferon-γ-elicited responses of primary mouse microglia in vitro and limited their ability to induce T cell activation and proliferation in T cell-microglia co-cultures. Additionally, we observed reduced peripheral T cell numbers in our EAE model, with a pronounced shift to immunosenescent and regulatory T cell subsets, a pattern which we similarly detected in a cohort of SPMS patients following siponimod treatment. These findings indicate that siponimod dampens compartmentalized CNS inflammation by disrupting detrimental interactions between T cells and microglia through a dual central and peripheral mechanism of action.
Author(s)
Husseini, Leila
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Geladaris, Anastasia
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Steinleitner, Marlene C.J.
Universitätsmedizin Göttingen
Häusler, Darius
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Weber, Martin S.  
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Journal
Acta Neuropathologica Communications  
Open Access
File(s)
Download (5.15 MB)
Rights
CC BY 4.0: Creative Commons Attribution
DOI
10.1186/s40478-025-02136-3
10.24406/publica-7497
Additional link
Full text
Language
English
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Keyword(s)
  • Microglia

  • Multiple sclerosis

  • Neurodegeneration

  • Progression

  • Siponimod

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024